Data coverage, completeness and provenance for CERETAS LIMITED in the Stock Market API — Health Care · Medical Care Facilities.
Ceretas Limited, a medical technology company that develops portable and non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions in Australia. The company's technology operates through two primary mechanisms, including neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits; and BBBO, which temporarily and reversibly opens the blood-brain barrier using ultrasound combined with circulating microbubbles that facilitates brain's natural clearance of amyloid-beta and tau and helps delivery of co-administered drugs to targeted brain regions. Ceretas Limited was incorporated in 2024 and is based in Brisbane, Australia.
Website: https://ceretas.com.au · Profile fields populated: 50%
Every number on this page is one API call away. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/CTS
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/CTS/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/CTS/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/CTS/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/CTS/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/CTS
Free tier — instant API key. Built for AI agents.